Afișare rezultate

SM ISO690:2012

Pneumonology quiz – Case 3

Corlăteanu Alexandru1, Botnaru Victor1, Mathioudakis Alexander23, Rusu Doina1, Scutaru Eugenia1

1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,

Archives of Hellenic Medicine

Nr. 4(33) / 2016 / ISSN - /ISSNe 1105-3992

Disponibil online 3 August, 2022. Descarcări-0. Vizualizări-246

-----------------------------------------------------------------------------------------------------------------------------------

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials

Vanhoutte Frederic P.1, Mazur Minodora2, Voloshyn Oleksandr I.3, Stanislavchuk N.4, Van Der Aa Annegret1, Namour Florence5, Galien Rene5, Meuleners Luc1, Van't Klooster Gerben1

2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,

Arthritis and Rheumatology

Nr. 10(69) / 2017 / ISSN 2326-5191

Disponibil online 7 February, 2018. Descarcări-1. Vizualizări-723

-----------------------------------------------------------------------------------------------------------------------------------

Inflamația în patologia coronariană

Plugaru Ana, Munteanu (Ivanov) Mihaela

Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale

Nr. 1(61) / 2019 / ISSN 1857-0011

Disponibil online 12 April, 2019. Descarcări-13. Vizualizări-804

-----------------------------------------------------------------------------------------------------------------------------------

Hypersensitivity Pneumonitis: Challenges of a Complex Disease

Calaraş Diana1, David Aliona2, Vasarmidi Eirini3, Antoniou Katerina M.3, Corlăteanu Alexandru1

1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 2 Institute of Phtysiopneumology „Chiril Draganiuc”, 3 University of Crete Medical School, Crete

Canadian Respiratory Journal

Nr. / 2024 / ISSN 1198-2241 /ISSNe 1916-7245

Disponibil online 19 February, 2024. Descarcări-1. Vizualizări-62

-----------------------------------------------------------------------------------------------------------------------------------

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

Singh Dave123, Boguş Maxim4, Moskalenko Valentyn5, Noi Autori

3 Brovary multidisciplinary clinical hospital, 4 Timofei Moșneaga Republican Clinical Hospital,

European Respiratory Journal

Nr. / 2021 / ISSN 0903-1936 /ISSNe 1399-3003

Disponibil online 19 July, 2023. Descarcări-0. Vizualizări-164

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000